Financial Data and Key Metrics Changes - Revenue for the 12-month period grew 12% year-over-year, reaching BRL 3,697 million, with adjusted EBITDA growth of over 50% year-over-year, reaching BRL 1,680 million [4][5] - Adjusted EBITDA margin for the same period reached 45.4%, an increase of 130 basis points over last year [4][25] - Net income reached BRL 768.4 million, an 18% growth year-over-year, with basic EPS reaching BRL 8.32, a 19% increase compared to last year [5][26] - Cash flow from operating activities ended the 12-month period at BRL 1,548 million, over 6% higher than last year, with a cash conversion of 93.7% [4][25] Business Line Data and Key Metrics Changes - The number of undergraduate medical students grew by 5% year-over-year, reaching over 25,000 students, with approved medical seats increasing by 5% [19] - Continuing education segment revenue grew by 11% year-over-year, reaching BRL 284 million, with B2B revenue growth at 48% [7][20] - Medical practice solutions revenue increased by 6% year-over-year, reaching BRL 171 million [7][23] Market Data and Key Metrics Changes - The ecosystem reached 301,000 active users, reflecting strong engagement among physicians and medical students across Brazil [7][9] - The number of active payers in medical practice solutions reached 196,000, with physicians making over 16.9 million prescriptions using the solutions [9][23] Company Strategy and Development Direction - The company aims to strengthen its position across the entire physician lifecycle, expanding its audience and deepening engagement [11][12] - Investments will focus on integrating products and services for physicians, enhancing the user experience, and creating a unified platform [36][37] - The company plans to maintain a balanced capital allocation strategy, focusing on sustainable cash generation, growth investments, and shareholder returns [10][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving another strong year in 2026, with revenue guidance between BRL 3.95 billion and BRL 4.1 billion [16][17] - The company does not expect any material impact from ENAMED on its 2026 guidance, with preparations in place for upcoming evaluations [17][46] - Management highlighted the importance of integrating technology and enhancing product offerings to drive future growth [36][37] Other Important Information - A cash dividend of BRL 307.4 million was announced, representing 40% of the 2025 net income, payable in April 2026 [10][11] - The company maintains a conservative leverage profile with a net debt of BRL 1,369 million, a reduction of BRL 445 million from the end of 2024 [29] Q&A Session All Questions and Answers Question: Focus on continuing education and medical practice solutions transformation - Management discussed integrating products and services for physicians under a unified platform, enhancing user experience and audience engagement [36][37] Question: Progress on ENAMED and PROFIMED discussions - Management indicated no expected impact from ENAMED on 2026 guidance and detailed preparations for upcoming evaluations [46][48] Question: Operational expenses and CapEx increase - Management explained that the increase in intangible assets was due to new investment programs initiated in Q4 2025, and operational expenses were managed effectively [55][56] Question: Capital allocation priorities - Management emphasized the flexibility in capital allocation due to strong free cash flow, focusing on M&A, dividends, and share buybacks [62][63] Question: Revenue growth breakdown by segment - Management provided insights that undergraduate growth would be in single digits, while continuing education and SPM segments would see double-digit growth [75]

Core Viewpoint - The company firmly opposes the trend of "involution" in competition and aims to defend its market position despite intensified competition, focusing on fundamental aspects such as reliable delivery and affordable pricing [1][5][24]. Financial Performance - In Q2, the company's adjusted net profit dropped nearly 90% year-on-year, significantly below market expectations, due to fierce competition [3][20]. - Revenue increased by 11.7% year-on-year, reaching 91.81 billion RMB, with core local business revenue growing by 7.7% to 65.3 billion RMB [19][21]. Business Strategy - The company is restructuring its fresh food business by significantly reducing the scale of Meituan Youxuan and fully investing in Xiaoxiang Supermarket, aiming to cover all first- and second-tier cities [1][41][42]. - The company plans to expand its overseas business, with Keeta entering Qatar and setting a ten-year GMV target of 100 billion USD, while remaining patient about growth [1][5][45]. Market Position and User Engagement - The company reported over 600 million monthly active users, with a record high in transaction frequency, indicating its growing preference among consumers for local service platforms [7][8]. - The company is focused on enhancing user loyalty and attracting new users through high-quality, cost-effective products and reliable service experiences [8][12]. Competitive Landscape - The management anticipates that intense competition will persist in the short term, negatively impacting financial results, but emphasizes the resilience of its core local business [4][24]. - The company is committed to maintaining its competitive edge by focusing on operational efficiency and enhancing service quality, despite the challenges posed by high subsidy levels in the industry [20][29]. Future Outlook - The company expresses confidence in its ability to achieve long-term healthy growth, despite short-term fluctuations and competitive pressures [24][31]. - The company aims to leverage its operational advantages and continue investing in its ecosystem to foster sustainable growth and enhance consumer experience [17][29].

Core Viewpoint - Pinduoduo's net profit declined in Q2 due to intense competition in the e-commerce sector and increased support for merchants, but results were significantly better than market expectations. The management emphasized a commitment to long-term value creation over short-term profits [1][4]. Financial Performance - In Q2, Pinduoduo achieved revenue of $37 billion, representing a year-on-year growth of 10% [8]. - Operating profit decreased by 21% year-on-year, reflecting the impact of substantial investments in merchant support and ecosystem development [4]. Strategic Initiatives - The company launched the "100 Billion Support Plan," which involves significant resource allocation to support the merchant ecosystem and explore new business models globally [4][5]. - Pinduoduo's initiatives have led to a 40% increase in order volume for remote areas, enhancing the quality of life for consumers in those regions [4]. Long-term Focus - Management reiterated the importance of long-term investments in ecosystem building and consumer experience, indicating that profitability may fluctuate as a result of these strategies [6][9]. - The company is prioritizing high-quality growth and is willing to sacrifice short-term profits for sustainable development [1][6].